T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer

• Published in: International journal of molecular sciences Vol. 23; no. 15; p. 8590
• Main Authors: Mazzotti, Lucia, Gaimari, Anna, Bravaccini, Sara, Maltoni, Roberta, Cerchione, Claudio, Juan, Manel, Navarro, Europa Azucena-Gonzalez, Pasetto, Anna, Nascimento Silva, Daniela, Ancarani, Valentina, Sambri, Vittorio, Calabrò, Luana, Martinelli, Giovanni, Mazza, Massimiliano
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01-08-2022; MDPI
• Subjects: Adaptive immunity; Antigens; Cancer; cancer immunotherapy; Enzymes; Histocompatibility antigen HLA; HLA; Immune system; Immunology; Infectious diseases; Lymphocytes; Lymphocytes B; Lymphocytes T; Medicin och hälsovetenskap; Next-generation sequencing; Pathogens; Peptides; Proteins; Review; Severe acute respiratory syndrome coronavirus 2; T cell receptors; TCR repertoire; TCR sequencing; Thymus gland; TILs; Viral infections
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms23158590

The immune system is a dynamic feature of each individual and a footprint of our unique internal and external exposures. Indeed, the type and level of exposure to physical and biological agents shape the development and behavior of this complex and diffuse system. Many pathological conditions depend on how our immune system responds or does not respond to a pathogen or a disease or on how the regulation of immunity is altered by the disease itself. T-cells are important players in adaptive immunity and, together with B-cells, define specificity and monitor the internal and external signals that our organism perceives through its specific receptors, TCRs and BCRs, respectively. Today, high-throughput sequencing (HTS) applied to the TCR repertoire has opened a window of opportunity to disclose T-cell repertoire development and behavior down to the clonal level. Although TCR repertoire sequencing is easily accessible today, it is important to deeply understand the available technologies for choosing the best fit for the specific experimental needs and questions. Here, we provide an updated overview of TCR repertoire sequencing strategies, providers and applications to infectious diseases and cancer to guide researchers’ choice through the multitude of available options. The possibility of extending the TCR repertoire to HLA characterization will be of pivotal importance in the near future to understand how specific HLA genes shape T-cell responses in different pathological contexts and will add a level of comprehension that was unthinkable just a few years ago.